24 research outputs found
Genetic variability among Blastoschizomyces capitatus isolates from different clinical sources.
Sixteen clinical isolates and nine ATCC reference strains of Blastoschizomyces capitatus were analysed genetically, examined for the cellobiose, arbutin and salicin assimilation and tested for the aspartyl-proteinase secretion. The restriction endonuclease analysis (REA) with HpaII and HinfI enzymes and the electrophoretic karyotype (EK) were investigated. Both the restriction enzymes revealed two groups (I, II) constituted by the same isolates: 17 isolates (68%) in group I and 8 (32%) in group II. The EK analysis revealed sixteen groups. These data prompts for a genetic variability of the isolates of Blastoschizomyces capitatus and their account in two distinct genetic groups as suggested by REA. This grouping was confirmed by examing the utilisation of cellobiose, arbutin and salicin. The tests for secretory aspartyl proteinase (Sap) were positive only for three isolates, suggesting a marginal role of this specific enzyme in pathogenesis for these isolates
Performance of the diamond active target prototype for the PADME experiment at the DANE BTF
The PADME experiment at the DANE Beam-Test Facility (BTF) is designed
to search for the gauge boson of a new interaction in the process
ee+, using the intense positron beam hitting a
light target. The , usually referred as dark photon, is assumed to
decay into invisible particles of a secluded sector and it can be observed by
searching for an anomalous peak in the spectrum of the missing mass measured in
events with a single photon in the final state. The measurement requires the
determination of the 4-momentum of the recoil photon, performed by a
homogeneous, highly segmented BGO crystals calorimeter. A significant
improvement of the missing mass resolution is possible using an active target
capable to determine the average position of the positron bunch with a
resolution of less than 1 mm. This report presents the performance of a real
size PADME active target made of a thin (50 m) diamond
sensor, with graphitic strips produced via laser irradiation on both sides. The
measurements are based on data collected in a beam test at the BTF in November
2015.Comment: 7 pages, 10 figure
Multidisciplinary approach to constrain kinematics of fault zones at shallow depths: a case study from the Cameros–Demanda thrust (North Spain)
Determining transport direction in thrusts is one of the main issues to study deformation and to achieve reliable balanced cross-sections reconstruction of inverted basins and thrust systems. Anisotropy of Magnetic Susceptibility provides a tool to study deformation in fault rocks through the relationships between the magnetic susceptibility ellipsoid and deformational structures. The Cameros-Demanda Thrust (N Spain) shows a relatively simple history, with an average N-directed movement during the Cenozoic, and provides the possibility of determining the relationships between magnetic fabrics and transport directions in thrusts. The outcropping rocks are Mesozoic limestones in the hangingwall of the main thrust and Cenozoic conglomerates and Albian sandstones and coal in its footwall. Illite crystallinity and organic matter maturity indicate P-T conditions on the order of....The study of AMS in fault rocks (more than 400 samples distributed in 25 sites with fault gouge, breccia and microbreccia) in the Cameros thrust and its comparison with kinematic indicators (foliation, S/C structures and slickenside striations) indicates, in spite of the a priori simple relationships inferred from thrust geometry, a complex history of movements, changing from top-to-the-NW to top-to-the-NE along the history of Cenozoic thrusting. The transport direction is either oblique to the magnetic lineation and perpendicular to the strike of magnetic foliation, and can be checked with shear structures observed in thin sections and other kinematic indicators. The results obtained indicate that AMS can give clues about the transport direction in thrusts depending on the particular structures developed in each studied area
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research
Unraveling the deformational history of faults from AMS EGU 2014 – 27 April – 2 Mai Session EMRP3.5 Anisotropy of Magnetic Susceptibility: Recent advances and novel applications.
Proteolysis of MOB1 by the ubiquitin ligase praja2 attenuates Hippo signalling and supports glioblastoma growth.
Human glioblastoma is the most frequent and aggressive form of brain tumour in the adult population. Proteolytic turnover of tumour suppressors by the ubiquitin-proteasome system is a mechanism that tumour cells can adopt to sustain their growth and invasiveness. However, the identity of ubiquitin-proteasome targets and regulators in glioblastoma are still unknown. Here we report that the RING ligase praja2 ubiquitylates and degrades Mob, a core component of NDR/LATS kinase and a positive regulator of the tumour-suppressor Hippo cascade. Degradation of Mob through the ubiquitin-proteasome system attenuates the Hippo cascade and sustains glioblastoma growth in vivo. Accordingly, accumulation of praja2 during the transition from low- to high-grade glioma is associated with significant downregulation of the Hippo pathway. These findings identify praja2 as a novel upstream regulator of the Hippo cascade, linking the ubiquitin proteasome system to deregulated glioblastoma growth